Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Associate Professor
Language English
Title Impact of Baseline Low-Density Lipoprotein cholesterole Level and Aggressive Lipid-Lowering Therapy by Ezetimibe on Prognosis of Statin Naive Acute Coronary Syndrome Patients: A Sub-Analysis of the HIJ-PROPER Trial
Conference American Heart Association (AHA) Scientific Sessions 2018
Promoters American Heart Association (AHA)
Conference Type International society and overseas society
Presentation Type Poster notice
Lecture Type General
Publisher and common publisher◎WATANABE Erisa, YAMAGUCHI Junichi, SEKIGUCHI Haruki, IM Jihaeng, SUZUKI Keisuke, OGISO Masataka, ARASHI Hiroyuki, OGAWA Hiroshi, HAGIWARA Nobuhisa, and HIJ-PROPER Investigators
Date 2018/11/10
(city and name of the country)
Chicago, USA
Summary *Session Title: Lipids, Lipoproteins and Risk of Coronary Artery Disease

Conclusions: In statin naïve ACS patients showing LDL-C value less than 140mg/dl on admission, intensive lipid lowering therapy, adding ezetimibe to pitavastatin, did not improve clinical outcome in comparison with pitavastatin monotherapy, regardless significant lower LDL-C value after 3-year. Another approach, other than ezetimibe, for lipid lowering should be warranted in this population.